Depressive Disorders - Taiwan

Taiwan

Revenue in the Depressive Disorders market is projected to reach US$328.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.52%, resulting in a market volume of US$407.80m by 2028.
In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
In relation to total population figures, per person revenues of US$399.80 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Depressive Disorders market in Taiwan has been experiencing significant growth in recent years.

Customer preferences: Customers in Taiwan have shown a growing preference for seeking treatment for depressive disorders. This can be attributed to several factors, including increased awareness and understanding of mental health issues, as well as a decrease in the stigma surrounding mental health. Additionally, the availability of a wide range of treatment options, including medication, therapy, and alternative therapies, has also contributed to the growing demand for treatment.

Trends in the market: One of the key trends in the Depressive Disorders market in Taiwan is the increasing use of technology in the treatment of depression. Telemedicine and online therapy platforms have gained popularity, allowing patients to access treatment from the comfort of their own homes. This trend has been further accelerated by the COVID-19 pandemic, which has limited in-person interactions and increased the need for remote healthcare services.Another trend in the market is the growing focus on holistic approaches to treatment. Many patients are seeking alternative therapies, such as acupuncture, yoga, and mindfulness, in addition to traditional medication and therapy. This trend reflects a shift towards a more integrated approach to mental health, with patients looking for a combination of medical and non-medical interventions to manage their depressive disorders.

Local special circumstances: Taiwan has a well-developed healthcare system, which includes both public and private providers. This has contributed to the accessibility and availability of treatment options for depressive disorders. Additionally, the Taiwanese government has implemented various initiatives to promote mental health and improve access to treatment, such as increasing the number of mental health professionals and providing subsidies for mental health services.

Underlying macroeconomic factors: Taiwan has experienced steady economic growth in recent years, which has led to an increase in disposable income and healthcare spending. This has allowed more individuals to afford treatment for depressive disorders and has contributed to the growth of the market. Additionally, the aging population in Taiwan has also played a role in the growth of the Depressive Disorders market, as older individuals are more likely to experience depressive symptoms and seek treatment.In conclusion, the Depressive Disorders market in Taiwan is experiencing significant growth due to increasing customer preferences for treatment, the adoption of technology in healthcare, the focus on holistic approaches, the accessibility of healthcare services, and the underlying macroeconomic factors such as economic growth and an aging population. The market is expected to continue growing in the coming years as the demand for treatment for depressive disorders continues to rise.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.